ROHTO PHARMACEUTICAL CO.,LTD. 4527Short Interest
Estimated short interest in ROHTO PHARMACEUTICAL CO.,LTD. (4527) is 7.89% of shares outstanding as of 2025-10-01. Institutions holding 0.5% or more: BNP Paribas Financial Markets SNC.
Estimated short interest
7.89%
▼0.18%
Estimated position (shares)
1,289,331
As of 2025-10-01
Short sellers
4 firms
9 reports
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest, stacking the latest reported position of each short seller. The 4 largest current holders are shown in color and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- BNP Paribas Financial Markets SNC
- Barclays Bank PLC
- MERRILL LYNCH INTERNATIONAL
- Integrated Core Strategies (Asia) Pte. Ltd.
7.89%
Estimated short interest, 2025-10-01
Integrated Core Strategies (Asia) Pte. Ltd.0.07%
MERRILL LYNCH INTERNATIONAL0.13%
Barclays Bank PLC0.37%
BNP Paribas Financial Markets SNC7.32%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2025-08-12 | BNP Paribas Financial Markets SNC | Position 173 shares | Ratio 7.32% | ▲7.09% | Holding |
| 2025-10-01 | Barclays Bank PLC | Position 887,638 shares | Ratio 0.37% | ▼0.18% | Below 0.5% |
| 2025-01-06 | MERRILL LYNCH INTERNATIONAL | Position 308,760 shares | Ratio 0.13% | ▼0.37% | Below 0.5% |
| 2022-10-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 92,760 shares | Ratio 0.07% | ▼0.43% | Below 0.5% |
Disclosure History 9 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2025-10-01 | Barclays Bank PLC | Position 887,638 shares | Ratio 0.37% | ▼0.18% | Below 0.5% |
| 2025-09-16 | Barclays Bank PLC | Position 1,317,574 shares | Ratio 0.55% | ▲0.17% | — |
| 2025-08-12 | BNP Paribas Financial Markets SNC | Position 173 shares | Ratio 7.32% | ▲7.09% | — |
| 2025-08-05 | BNP Paribas Financial Markets SNC | Position 1,149,673 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2025-08-01 | BNP Paribas Financial Markets SNC | Position 1,212,073 shares | Ratio 0.51% | ▲0.11% | — |
| 2025-01-06 | MERRILL LYNCH INTERNATIONAL | Position 308,760 shares | Ratio 0.13% | ▼0.37% | Below 0.5% |
| 2024-12-30 | MERRILL LYNCH INTERNATIONAL | Position 1,202,019 shares | Ratio 0.50% | ▲0.50% | — |
| 2022-10-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 92,760 shares | Ratio 0.07% | ▼0.43% | Below 0.5% |
| 2022-10-21 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 599,239 shares | Ratio 0.50% | ▲0.09% | — |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Sumitomo Pharma Co.,Ltd.4506 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |